<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34559059</PMID><DateRevised><Year>2021</Year><Month>12</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-0748</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>11</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>Longitudinal Neurocognitive and Pulmonological Profile of Long COVID-19: Protocol for the COVIMMUNE-Clin Study.</ArticleTitle><Pagination><StartPage>e30259</StartPage><MedlinePgn>e30259</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e30259</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/30259</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is a dearth of information about "brain fog," characterized by concentration, word-finding, or memory problems, which has been listed in the new World Health Organization provisional classification "U09.9 Post-COVID-19 Condition." Moreover, the extent to which these symptoms may be associated with neurological, pulmonary, or psychiatric difficulties is unclear.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This ongoing cohort study aims to carefully assess neurocognitive function in the context of the neurological, psychiatric, and pulmonary sequelae of SARS-CoV-2 infection among patients with asymptomatic/mild and severe cases of COVID-19 after remission, including actively recruited healthy controls.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 150 participants will be included in this pilot study. The cohort will comprise patients who tested positive for SARS-CoV-2 infection with either an asymptomatic course or a mild course defined as no symptoms except for olfactory and taste dysfunction (n=50), patients who tested positive for SARS-CoV-2 infection with a severe disease course (n=50), and a healthy control group (n=50) with similar age and sex distribution based on frequency matching. A comprehensive neuropsychological assessment will be performed comprising nuanced aspects of complex attention, including language, executive function, verbal and visual learning, and memory. Psychiatric, personality, social and lifestyle factors, sleep, and fatigue will be evaluated. Brain magnetic resonance imaging, neurological and physical assessment, and pulmonological and lung function examinations (including body plethysmography, diffusion capacity, clinical assessments, and questionnaires) will also be performed. Three visits are planned with comprehensive testing at the baseline and 12-month visits, along with brief neurological and neuropsychological examinations at the 6-month assessment. Blood-based biomarkers of neurodegeneration will be quantified at baseline and 12-month follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At the time of submission, the study had begun recruitment through telephone and in-person screenings. The first patient was enrolled in the study at the beginning of April 2021. Interim data analysis of baseline information is expected to be complete by December 2021 and study completion is expected at the end of December 2022. Preliminary group comparisons indicate worse word list learning, short- and long-delayed verbal recall, and verbal recognition in both patient cohorts compared with those of the healthy control group, adjusted for age and sex. Initial volumetric comparisons show smaller grey matter, frontal, and temporal brain volumes in both patient groups compared with those of healthy controls. These results are quite robust but are neither final nor placed in the needed context intended at study completion.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">To the best of our knowledge, this is the first study to include objective and comprehensive longitudinal analyses of neurocognitive sequelae of COVID-19 in an extreme group comparison stratified by disease severity with healthy controls actively recruited during the pandemic. Results from this study will contribute to the nascent literature on the prolonged effects of COVID-19 on neurocognitive performance via our coassessment of neuroradiological, neurological, pulmonary, psychiatric, and lifestyle factors.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">International Clinical Trials Registry Platform DRKS00023806; https://trialsearch.who.int/Trial2.aspx?TrialID=DRKS00023806.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">DERR1-10.2196/30259.</AbstractText><CopyrightInformation>&#xa9;Catherine N Widmann, Michelle Wieberneit, Luzie Bieler, Sarah Bernsen, Robin Gr&#xe4;fenk&#xe4;mper, Frederic Brosseron, Carsten Schmeel, Pawel Tacik, Dirk Skowasch, Alexander Radbruch, Michael T Heneka. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 11.11.2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Widmann</LastName><ForeName>Catherine N</ForeName><Initials>CN</Initials><Identifier Source="ORCID">0000-0001-8889-8385</Identifier><AffiliationInfo><Affiliation>Section Neuropsychology, Department of Neurodegenerative Diseases and Gerontopsychiatry, University of Bonn Medical Center, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wieberneit</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2935-3446</Identifier><AffiliationInfo><Affiliation>Section Neuropsychology, Department of Neurodegenerative Diseases and Gerontopsychiatry, University of Bonn Medical Center, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bieler</LastName><ForeName>Luzie</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1216-6046</Identifier><AffiliationInfo><Affiliation>Section Neuropsychology, Department of Neurodegenerative Diseases and Gerontopsychiatry, University of Bonn Medical Center, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernsen</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7485-2626</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Diseases and Gerontopsychiatry, University of Bonn Medical Center, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xe4;fenk&#xe4;mper</LastName><ForeName>Robin</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9649-8373</Identifier><AffiliationInfo><Affiliation>Section Neuropsychology, Department of Neurodegenerative Diseases and Gerontopsychiatry, University of Bonn Medical Center, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Bonn Medical Center, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brosseron</LastName><ForeName>Frederic</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3137-7516</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmeel</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0985-1517</Identifier><AffiliationInfo><Affiliation>Department of Neuroradiology, University of Bonn Medical Center, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tacik</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4234-5635</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Diseases and Gerontopsychiatry, University of Bonn Medical Center, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skowasch</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2377-5936</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Pneumology and Angiology, Internal Medicine II, University of Bonn Medical Center, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radbruch</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6238-6525</Identifier><AffiliationInfo><Affiliation>Department of Neuroradiology, University of Bonn Medical Center, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heneka</LastName><ForeName>Michael T</ForeName><Initials>MT</Initials><Identifier Source="ORCID">0000-0003-4996-1630</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Diseases and Gerontopsychiatry, University of Bonn Medical Center, Bonn, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">lung</Keyword><Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">neuropsychology</Keyword><Keyword MajorTopicYN="N">postacute COVID-19 syndrome</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>24</Day><Hour>12</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34559059</ArticleId><ArticleId IdType="pmc">PMC8589042</ArticleId><ArticleId IdType="doi">10.2196/30259</ArticleId><ArticleId IdType="pii">v10i11e30259</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, Chu HY. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021 Feb 01;4(2):e210830. doi: 10.1001/jamanetworkopen.2021.0830. 
 
2776560</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, DiBiase RM, Jia DT, Balabanov R, Ho SU, Batra A, Liotta EM, Koralnik IJ. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021 May;8(5):1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu H, Shi C, Hu S. The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res. 2020 Oct;129:98&#x2013;102. doi: 10.1016/j.jpsychires.2020.06.022. 
 
S0022-3956(20)30854-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2020.06.022</ArticleId><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi C, Kang L, Yao S, Ma Y, Li T, Liang Y, Cheng Z, Xu Y, Shi J, Xu X, Zhang C, Franklin DR, Heaton RK, Jin H, Yu X. The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China. Schizophr Res. 2015 Dec;169(1-3):109&#x2013;115. doi: 10.1016/j.schres.2015.09.003. 
 
S0920-9964(15)00472-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.schres.2015.09.003</ArticleId><ArticleId IdType="pmc">PMC4916953</ArticleId><ArticleId IdType="pubmed">26441005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R, Dini M, Groppo E, Rosci C, Reitano MR, Bai F, Poletti B, Brugnera A, Silani V, D'Arminio Monforte A, Priori A. Long-lasting cognitive abnormalities after COVID-19. Brain Sci. 2021 Feb 13;11(2):235. doi: 10.3390/brainsci11020235. 
 
brainsci11020235</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11020235</ArticleId><ArticleId IdType="pmc">PMC7917789</ArticleId><ArticleId IdType="pubmed">33668456</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato MP, Portaccio E, Goretti B, Zipoli V, Ricchiuti L, De Caro MF, Patti F, Vecchio R, Sorbi S, Trojano M. The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler. 2006 Dec;12(6):787&#x2013;793. doi: 10.1177/1352458506070933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458506070933</ArticleId><ArticleId IdType="pubmed">17263008</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020 Nov;16(11):636&#x2013;644. doi: 10.1038/s41582-020-0398-3. 
 
10.1038/s41582-020-0398-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0398-3</ArticleId><ArticleId IdType="pmc">PMC7444680</ArticleId><ArticleId IdType="pubmed">32839585</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020 Jun 04;12(1):69. doi: 10.1186/s13195-020-00640-3. 
 
10.1186/s13195-020-00640-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00640-3</ArticleId><ArticleId IdType="doi">10.1186/s13195-020-00640-3</ArticleId><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021 May;8(5):416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5. 
 
S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T. Neurological associations of COVID-19. Lancet Neurol. 2020 Sep;19(9):767&#x2013;783. doi: 10.1016/S1474-4422(20)30221-0. 
 
S1474-4422(20)30221-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 May;20(5):533&#x2013;534. doi: 10.1016/S1473-3099(20)30120-1. 
 
S1473-3099(20)30120-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 SUFTE, as OM1, 2021 I. COVID-19 situation update for the EU/EEA, as of 18 October 2021. European Center for Disease Control.  [2021-30-07].  
 https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea
.</Citation></Reference><Reference><Citation>Tsori Y, Granek R. Epidemiological model for the inhomogeneous spatial spreading of COVID-19 and other diseases. PLoS One. 2021;16(2):e0246056. doi: 10.1371/journal.pone.0246056. 
 
PONE-D-20-21655</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246056</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0246056</ArticleId><ArticleId IdType="pmc">PMC7894958</ArticleId><ArticleId IdType="pubmed">33606684</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistical Yearbook 2020, Sixty-third Issue. UN-iLibrary.  [2021-05-10].  
 https://www.un-ilibrary.org/content/books/9789210050784
.</Citation></Reference><Reference><Citation>Chen R, Wang K, Yu J, Howard D, French L, Chen Z, Wen C, Xu Z. The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol. 2020;11:573095. doi: 10.3389/fneur.2020.573095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.573095</ArticleId><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, Sperhake JP, Schr&#xf6;der AS, Edler C, Mushumba H, Fitzek A, Allweiss L, Dandri M, Dottermusch M, Heinemann A, Pfefferle S, Schwabenland M, Sumner Magruder D, Bonn S, Prinz M, Gerloff C, P&#xfc;schel K, Krasemann S, Aepfelbacher M, Glatzel M. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020 Nov;19(11):919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2. 
 
S1474-4422(20)30308-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Tan B, Wu S, Gui Y, Suo J, Li Y. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection. J Med Virol. 2021 Mar;93(3):1304&#x2013;1313. doi: 10.1002/jmv.26570. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26570</ArticleId><ArticleId IdType="pmc">PMC7537172</ArticleId><ArticleId IdType="pubmed">33002209</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurink B, Roos E, Radonic T, Barbe E, Bouman CSC, de Boer HH, de Bree GJ, Bulle EB, Aronica EM, Florquin S, Fronczek J, Heunks LMA, de Jong MD, Guo L, du Long R, Lutter R, Molenaar PCG, Neefjes-Borst EA, Niessen HWM, van Noesel CJM, Roelofs JJTH, Snijder EJ, Soer EC, Verheij J, Vlaar APJ, Vos W, van der Wel NN, van der Wal AC, van der Valk P, Bugiani M. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe. 2020 Nov;1(7):e290&#x2013;e299. doi: 10.1016/S2666-5247(20)30144-0. 
 
S2666-5247(20)30144-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30144-0</ArticleId><ArticleId IdType="pmc">PMC7518879</ArticleId><ArticleId IdType="pubmed">33015653</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmann CN, Heneka MT. Long-term cerebral consequences of sepsis. Lancet Neurol. 2014 Jun;13(6):630&#x2013;636. doi: 10.1016/S1474-4422(14)70017-1.S1474-4422(14)70017-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70017-1</ArticleId><ArticleId IdType="pubmed">24849863</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmler A, Frisch C, Debeir T, Ramanathan M, Okulla T, Klockgether T, Heneka MT. Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp Neurol. 2007 Apr;204(2):733&#x2013;740. doi: 10.1016/j.expneurol.2007.01.003.S0014-4886(07)00023-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2007.01.003</ArticleId><ArticleId IdType="pubmed">17306796</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowyer JF, Sarkar S, Burks SM, Hess JN, Tolani S, O'Callaghan JP, Hanig JP. Microglial activation and responses to vasculature that result from an acute LPS exposure. Neurotoxicology. 2020 Mar;77:181&#x2013;192. doi: 10.1016/j.neuro.2020.01.014. 
 
S0161-813X(20)30022-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2020.01.014</ArticleId><ArticleId IdType="pmc">PMC7294247</ArticleId><ArticleId IdType="pubmed">32014511</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellstrom IC, Danik M, Luheshi GN, Williams S. Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL-beta-dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons. Hippocampus. 2005;15(5):656&#x2013;664. doi: 10.1002/hipo.20086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.20086</ArticleId><ArticleId IdType="pubmed">15889405</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng X, Ai W, Lei D, Luo X, Yan X, Li Z. Lipopolysaccharide induces paired immunoglobulin-like receptor B (PirB) expression, synaptic alteration, and learning-memory deficit in rats. Neuroscience. 2012 May 03;209:161&#x2013;170. doi: 10.1016/j.neuroscience.2012.02.022.S0306-4522(12)00165-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2012.02.022</ArticleId><ArticleId IdType="pubmed">22395112</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiramoto RN, Rogers CF, Demissie S, Hsueh CM, Hiramoto NS, Lorden JF, Ghanta VK. Psychoneuroendocrine immunology: site of recognition, learning and memory in the immune system and the brain. Int J Neurosci. 1997 Dec;92(3-4):259&#x2013;285. doi: 10.3109/00207459708986405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207459708986405</ArticleId><ArticleId IdType="pubmed">9522270</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwashyna TJ. Trajectories of recovery and dysfunction after acute illness, with implications for clinical trial design. Am J Respir Crit Care Med. 2012 Aug 15;186(4):302&#x2013;304. doi: 10.1164/rccm.201206-1138ED. 
 
186/4/302</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201206-1138ED</ArticleId><ArticleId IdType="pmc">PMC3443808</ArticleId><ArticleId IdType="pubmed">22896591</ArticleId></ArticleIdList></Reference><Reference><Citation>Lage C, Gonz&#xe1;lez-Su&#xe1;rez A, Alcalde-Hierro MP, Sampedro-Gonz&#xe1;lez MI, Villanueva-Eguaras &#xc1;, S&#xe1;nchez-Crespo MR, Widmann CN, Brosseron F, Pozueta A, L&#xf3;pez-Garc&#xed;a S, Garc&#xed;a-Mart&#xed;nez M, Kazimierczak M, Bravo-Gonz&#xe1;lez M, Fern&#xe1;ndez-Rodr&#xed;guez A, Drake-P&#xe9;rez M, Irure-Ventura J, L&#xf3;pez-Hoyos M, Rodr&#xed;guez-Rodr&#xed;guez E, Heneka MT, S&#xe1;nchez-Juan P. Major surgery affects memory in individuals with cerebral amyloid-&#x3b2; pathology. J Alzheimers Dis. 2021;79(2):863&#x2013;874. doi: 10.3233/JAD-191229.JAD191229</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-191229</ArticleId><ArticleId IdType="pubmed">33361588</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmler A, Widmann CN, Okulla T, Urbach H, Kaiser M, Widman G, Mormann F, Weide J, Fliessbach K, Hoeft A, Jessen F, Putensen C, Heneka MT. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):62&#x2013;69. doi: 10.1136/jnnp-2012-302883.jnnp-2012-302883</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-302883</ArticleId><ArticleId IdType="pubmed">23134661</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmann CN, Schewe JC, Heneka MT. Sepsis-associated encephalopathy versus sepsis-induced encephalopathy--authors' reply. Lancet Neurol. 2014 Oct;13(10):968&#x2013;969. doi: 10.1016/S1474-4422(14)70204-2.S1474-4422(14)70204-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70204-2</ArticleId><ArticleId IdType="pubmed">25231518</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmann CN, Sinning J, Ghanem A, Brosseron F, Heneka M, Wagner M. [P2&#x2013;088]: Chronic and acute systemic inflammation and long-term cognitive decline. Alzheimers Dement. 2017 Jul 01;13(7S Part 13):P640&#x2013;P640. doi: 10.1016/j.jalz.2017.06.737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.06.737</ArticleId></ArticleIdList></Reference><Reference><Citation>Calsavara AJC, Nobre V, Barichello T, Teixeira AL. Post-sepsis cognitive impairment and associated risk factors: A&#xa0;systematic review. Aust Crit Care. 2018 Jul;31(4):242&#x2013;253. doi: 10.1016/j.aucc.2017.06.001.S1036-7314(17)30251-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aucc.2017.06.001</ArticleId><ArticleId IdType="pubmed">28645546</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins RO, Weaver LK, Collingridge D, Parkinson RB, Chan KJ, Orme JF. Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2005 Feb 15;171(4):340&#x2013;347. doi: 10.1164/rccm.200406-763OC.200406-763OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200406-763OC</ArticleId><ArticleId IdType="pubmed">15542793</ArticleId></ArticleIdList></Reference><Reference><Citation>Amtliche Bekanntmachungen Ordnung zur Sicherung guter wissenschaftlicher Praxis an der Rheinischen Friedrich-Wilhelms-Universit&#xe4;t Bonn. Rheinischen Friedrich-Wilhelms-Universit&#xe4;t Bonn. 2020. Sep 21,  [2020-09-02].  
 https://bonndoc.ulb.uni-bonn.de/xmlui/bitstream/handle/20.500.11811/8928/Amtl.%20Bek.%2021013.pdf?sequence=1&amp;isAllowed=y
.</Citation></Reference><Reference><Citation>World Medical Association World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81(3):14&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">25951678</ArticleId></ArticleIdList></Reference><Reference><Citation>Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation) (Text with EEA relevance) Publication Office of the European Union. 2016.  [2021-08-25].  
 http://op.europa.eu/en/publication-detail/-/publication/3e485e15-11bd-11e6-ba9a-01aa75ed71a1
.</Citation></Reference><Reference><Citation>Benedict RH, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test &#x2013; Revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 2010 Aug 09;12(1):43&#x2013;55. doi: 10.1076/clin.12.1.43.1726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1076/clin.12.1.43.1726</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017 Feb;60:1&#x2013;12. doi: 10.1016/j.bbi.2016.03.010. 
 
S0889-1591(16)30055-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2016.03.010</ArticleId><ArticleId IdType="pubmed">26995317</ArticleId></ArticleIdList></Reference><Reference><Citation>Nation DA, Sweeney MD, Montagne A, Sagare AP, D'Orazio LM, Pachicano M, Sepehrband F, Nelson AR, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Chui HC, Law M, Toga AW, Zlokovic BV. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019 Feb 14;25(2):270&#x2013;276. doi: 10.1038/s41591-018-0297-y. 
 
10.1038/s41591-018-0297-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0297-y</ArticleId><ArticleId IdType="pmc">PMC6367058</ArticleId><ArticleId IdType="pubmed">30643288</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018 Mar;14(3):133&#x2013;150. doi: 10.1038/nrneurol.2017.188. 
 
nrneurol.2017.188</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.188</ArticleId><ArticleId IdType="pmc">PMC5829048</ArticleId><ArticleId IdType="pubmed">29377008</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomaszewski Farias S, Mungas D, Harvey DJ, Simmons A, Reed BR, Decarli C. The measurement of everyday cognition: development and validation of a short form of the Everyday Cognition scales. Alzheimers Dement. 2011 Nov;7(6):593&#x2013;601. doi: 10.1016/j.jalz.2011.02.007. 
 
S1552-5260(11)00089-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.02.007</ArticleId><ArticleId IdType="pmc">PMC3211103</ArticleId><ArticleId IdType="pubmed">22055976</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegrist P, Maercker A. Deutsche Fassung der Short Screening Scale for DSM-IV Posttraumatic Stress Disorder. Aktueller Stand der Validierung (English: German Version of the Short Screening Scale for DSM-IV Posttraumatic Stress Disorder. Current Status of Validation) Trauma Gewalt. 2010 Aug;156(6):208&#x2013;213. 
 
</Citation></Reference><Reference><Citation>Wilson RS, Arnold SE, Schneider JA, Kelly JF, Tang Y, Bennett DA. Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology. 2006;27(3):143&#x2013;153. doi: 10.1159/000095761.95761</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000095761</ArticleId><ArticleId IdType="pubmed">16974109</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhard U. Zeitschrift f&#xfc;r Klinische Psychologie und Psychotherapie. G&#xf6;ttingen: Hogrefe; 1999. Apr, pp. 145&#x2013;146.</Citation></Reference><Reference><Citation>Hultsch DF, Hertzog C, Small BJ, Dixon RA. Use it or lose it: engaged lifestyle as a buffer of cognitive decline in aging? Psychol Aging. 1999;14(2):245&#x2013;263. doi: 10.1037/0882-7974.14.2.245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0882-7974.14.2.245</ArticleId><ArticleId IdType="pubmed">10403712</ArticleId></ArticleIdList></Reference><Reference><Citation>Plassman BL, Williams JW, Burke JR, Holsinger T, Benjamin S. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med. 2010 Aug 03;153(3):182&#x2013;193. doi: 10.7326/0003-4819-153-3-201008030-00258. 
 
0003-4819-153-3-201008030-00258</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-3-201008030-00258?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</ArticleId><ArticleId IdType="doi">10.7326/0003-4819-153-3-201008030-00258</ArticleId><ArticleId IdType="pubmed">20547887</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgart M, Snyder H, Carrillo M, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement. 2015 Jun;11(6):718&#x2013;726. doi: 10.1016/j.jalz.2015.05.016. 
 
S1552-5260(15)00197-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.05.016</ArticleId><ArticleId IdType="pubmed">26045020</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacioppo JT, Hawkley LC. Perceived social isolation and cognition. Trends Cogn Sci. 2009 Oct;13(10):447&#x2013;454. doi: 10.1016/j.tics.2009.06.005. 
 
S1364-6613(09)00147-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tics.2009.06.005</ArticleId><ArticleId IdType="pmc">PMC2752489</ArticleId><ArticleId IdType="pubmed">19726219</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Xu J, Liu Y, Zhu J, Liu N, Zeng W, Huang N, Rasch MJ, Jiang H, Gu X, Li X, Luo M, Li C, Teng J, Chen J, Zeng S, Lin L, Zhang X. A distinct entorhinal cortex to hippocampal CA1 direct circuit for olfactory associative learning. Nat Neurosci. 2017 Apr;20(4):559&#x2013;570. doi: 10.1038/nn.4517.nn.4517</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4517</ArticleId><ArticleId IdType="pubmed">28263300</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller CA, Grassinger E, Naka A, Temmel AFP, Hummel T, Kobal G. A self-administered odor identification test procedure using the "Sniffin' Sticks". Chem Senses. 2006 Jul;31(6):595&#x2013;598. doi: 10.1093/chemse/bjj064.bjj064</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjj064</ArticleId><ArticleId IdType="pubmed">16754696</ArticleId></ArticleIdList></Reference><Reference><Citation>Besser G, Liu DT, Renner B, Mueller CA. Self-administered testing of odor threshold and discrimination using Sniffin&#x2019; Sticks&#x2014;reviving the &#x201c;Odor-Curves-On-Paper&#x201d; method. Chem Percept. 2019 Apr 4;13(1):71&#x2013;77. doi: 10.1007/s12078-019-09263-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12078-019-09263-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramont L, Thoannes H, Volondat A, Chastang F, Millet M, Maquart F. Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med. 2005;43(11):1215&#x2013;1217. doi: 10.1515/CCLM.2005.210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/CCLM.2005.210</ArticleId><ArticleId IdType="pubmed">16232088</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter M, Wiltfang J, Vogelgsang J. Pre-analytical sampling and storage conditions of amyloid-&#x3b2; peptides in venous and capillary blood. J Alzheimers Dis. 2020;78(2):529&#x2013;535. doi: 10.3233/JAD-200777.JAD200777</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200777</ArticleId><ArticleId IdType="pubmed">33016918</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connell GC, Alder ML, Webel AR, Moore SM. Neuro biomarker levels measured with high-sensitivity digital ELISA differ between serum and plasma. Bioanalysis. 2019 Nov;11(22):2087&#x2013;2094. doi: 10.4155/bio-2019-0213. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/bio-2019-0213</ArticleId><ArticleId IdType="pmc">PMC7132632</ArticleId><ArticleId IdType="pubmed">31829739</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahn T, He&#xdf;ler J. Handbook Cognitive Functions Dementia, Short description CRD Version 2. 2nd edition. M&#xf6;dling, J&#xe4;nner: Schuhfried GmbH; 2019. pp. 1&#x2013;82.</Citation></Reference><Reference><Citation>Lekeu F, Magis D, Marique P, Delbeuck X, Bechet S, Guillaume B, Adam S, Petermans J, Moonen G, Salmon E. The California Verbal Learning Test and other standard clinical neuropsychological tests to predict conversion from mild memory impairment to dementia. J Clin Exp Neuropsychol. 2010 Feb;32(2):164&#x2013;173. doi: 10.1080/13803390902889606.911472235</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13803390902889606</ArticleId><ArticleId IdType="pubmed">19459119</ArticleId></ArticleIdList></Reference><Reference><Citation>Negrini F, Ferrario I, Mazziotti D, Berchicci M, Bonazzi M, de Sire A, Negrini S, Zapparoli L. Neuropsychological features of severe hospitalized coronavirus disease 2019 patients at clinical stability and clues for postacute rehabilitation. Arch Phys Med Rehabil. 2021 Jan;102(1):155&#x2013;158. doi: 10.1016/j.apmr.2020.09.376. 
 
S0003-9993(20)30961-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2020.09.376</ArticleId><ArticleId IdType="pmc">PMC7521874</ArticleId><ArticleId IdType="pubmed">32991870</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemanno F, Houdayer E, Parma A, Spina A, Del Forno A, Scatolini A, Angelone S, Brugliera L, Tettamanti A, Beretta L, Iannaccone S. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience. PLoS One. 2021;16(2):e0246590. doi: 10.1371/journal.pone.0246590. 
 
PONE-D-20-34568</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246590</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0246590</ArticleId><ArticleId IdType="pmc">PMC7870071</ArticleId><ArticleId IdType="pubmed">33556127</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V, Beer R, Schiefecker AJ, Kofler M, Lindner A, Mahlknecht P, Heim B, Limmert V, Sahanic S, Pizzini A, Sonnweber T, Tancevski I, Scherfler C, Zamarian L, Bellmann-Weiler R, Weiss G, Djamshidian A, Kiechl S, Seppi K, Loeffler-Ragg J, Pfausler B, Helbok R. Neurological outcome and quality of life 3&#xa0;months after COVID-19: A prospective observational cohort study. Eur J Neurol. 2021 Oct;28(10):3348&#x2013;3359. doi: 10.1111/ene.14803. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14803</ArticleId><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference><Reference><Citation>Mcloughlin BC, Miles A, Webb TE, Knopp P, Eyres C, Fabbri A, Humphries F, Davis D. Functional and cognitive outcomes after COVID-19 delirium. Eur Geriatr Med. 2020 Oct;11(5):857&#x2013;862. doi: 10.1007/s41999-020-00353-8. 
 
10.1007/s41999-020-00353-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41999-020-00353-8</ArticleId><ArticleId IdType="pmc">PMC7358317</ArticleId><ArticleId IdType="pubmed">32666303</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee for the COMEBAC Study Group. Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, Gasnier M, Lecoq A, Meyrignac O, Noel N, Baudry E, Bellin M, Beurnier A, Choucha W, Corruble E, Dortet L, Hardy-Leger I, Radiguer F, Sportouch S, Verny C, Wyplosz B, Zaidan M, Becquemont L, Montani D, Monnet X. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. 2021 Apr 20;325(15):1525&#x2013;1534. doi: 10.1001/jama.2021.3331. 
 
2777787</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak KW, Johnsen S, Sattler SM, Nielsen S, Kunalan K, Rungby J, Lapperre T, Porsberg CM. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021 May;46:39&#x2013;48. doi: 10.1016/j.euroneuro.2021.03.019. 
 
S0924-977X(21)00174-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, Mazibuko N, Williams SC, Barnby JM, Hellyer P, Mehta MA. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021 Sep;39:101044. doi: 10.1016/j.eclinm.2021.101044. 
 
S2589-5370(21)00324-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5. 
 
S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK. Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following COVID-19: systematic review and meta-synthesis. Neurol Neuroimmunol Neuroinflamm. 2021 Nov;8(6):e1080. doi: 10.1212/NXI.0000000000001080. 
 
8/6/e1080</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001080</ArticleId><ArticleId IdType="pmc">PMC8404207</ArticleId><ArticleId IdType="pubmed">34452974</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology. 2020 Aug;296(2):E119&#x2013;E120. doi: 10.1148/radiol.2020201187. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201187</ArticleId><ArticleId IdType="pmc">PMC7233386</ArticleId><ArticleId IdType="pubmed">32228363</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Fern&#xe1;ndez F, Sandoval Valencia H, Barbella-Aponte RA, Collado-Jim&#xe9;nez R, Ayo-Mart&#xed;n &#xd3;, Barrena C, Molina-Nuevo JD, Garc&#xed;a-Garc&#xed;a J, Lozano-Seti&#xe9;n E, Alcahut-Rodriguez C, Mart&#xed;nez-Mart&#xed;n &#xc1;, S&#xe1;nchez-L&#xf3;pez A, Segura T. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020 Oct 01;143(10):3089&#x2013;3103. doi: 10.1093/brain/awaa239. 
 
5869424</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa239</ArticleId><ArticleId IdType="pmc">PMC7454411</ArticleId><ArticleId IdType="pubmed">32645151</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barr&#xe9; syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020 May;19(5):383&#x2013;384. doi: 10.1016/S1474-4422(20)30109-5. 
 
S1474-4422(20)30109-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30109-5</ArticleId><ArticleId IdType="pmc">PMC7176927</ArticleId><ArticleId IdType="pubmed">32246917</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan K, Premi E, Pilotto A, Cristillo V, Benussi A, Libri I, Giunta M, Bockholt HJ, Liu J, Campora R, Pezzini A, Gasparotti R, Magoni M, Padovani A, Calhoun VD. Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19. Neurobiol Stress. 2021 May;14:100326. doi: 10.1016/j.ynstr.2021.100326. 
 
S2352-2895(21)00034-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ynstr.2021.100326</ArticleId><ArticleId IdType="pmc">PMC8041745</ArticleId><ArticleId IdType="pubmed">33869679</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, Wu J, Chen T, Li J, Zhang G, Wu D, Zhou Y, Zheng N, Cai A, Ning Q, Manyande A, Xu F, Wang J, Zhu W. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J Clin Invest. 2021 Apr 15;131(8):e147329. doi: 10.1172/JCI147329.147329</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI147329</ArticleId><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, Mei N, Wu PY, Huang CC, Jia T, Zhao Y, Wang D, Xiao A, Yin B. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study. EClinicalMedicine. 2020 Aug;25:100484. doi: 10.1016/j.eclinm.2020.100484. 
 
S2589-5370(20)30228-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Granja C, Amaro A, Dias C, Costa-Pereira A. Outcome of ICU survivors: a comprehensive review. The role of patient-reported outcome studies. Acta Anaesthesiol Scand. 2012 Oct 04;56(9):1092&#x2013;1103. doi: 10.1111/j.1399-6576.2012.02686.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2012.02686.x</ArticleId><ArticleId IdType="pubmed">22471617</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, Stowe J, Tessier E, Groves N, Dabrera G, Myers R, Campbell C, Amirthalingam G, Edmunds M, Zambon M, Brown K, Hopkins S, Chand M, Ramsay M. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med. 2021 Aug 12;385(7):585&#x2013;594. doi: 10.1056/NEJMoa2108891. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2108891</ArticleId><ArticleId IdType="pmc">PMC8314739</ArticleId><ArticleId IdType="pubmed">34289274</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>